Filing Manager
Atomico Advisors IV, Ltd.
Reporting Manager
Atomico Advisors IV, Ltd.
Symbol
HNGE
Shares outstanding
81,159,686 shares
Disclosed Ownership
4,139,144 shares
Ownership
5.1%
Form type
SCHEDULE 13G/A
Filing time
09 Mar 2026, 20:50:01 UTC
Date of event
18 Nov 2025
Previous filing
30 Jul 2025

Quoteable Key Fact

"Atomico Advisors IV, Ltd. disclosed 5.1% ownership in Hinge Health, Inc. Class A Common Stock, par value $0.00001 per share (HNGE) on 18 Nov 2025."

Quick Takeaways

  • Atomico Advisors IV, Ltd. filed SCHEDULE 13G/A for Hinge Health, Inc. Class A Common Stock, par value $0.00001 per share (HNGE).
  • Disclosed ownership: 5.1%.
  • Date of event: 18 Nov 2025.

What Changed

  • Previous schedule filing date: 30 Jul 2025.
  • Current filing was accepted on 09 Mar 2026, 20:50.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Atomico Advisors IV, Ltd. 5.1% 4,139,144 0 4,139,144 /s/ Nicole Ramroop Director
Atomico IV, L.P. 5.1% 4,139,144 0 4,139,144 /s/ Nicole Ramroop Director of Atomico Advisors IV, Ltd., its general partner
Atomico IV (Guernsey), L.P. 5.1% 4,139,144 0 4,139,144 /s/ Nicole Ramroop Director of Atomico Advisors IV, Ltd., its general partner
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .